Keywords: sandoz, completes, phase, iii, trials, il-3, completed

Sandoz Completes Phase III Trials Of IL-3

Article | 26 September 1994

Print This

Sandoz has completed Phase III trials of its recombinant interleukin-3, a therapy which may be of use in preventing or ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in